NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-244-2015-0-JP-08 Brachyury Deletion Mutants, Non-Yeast Vectors Encoding Brachyury Deletion Mutants, and Their Use JP National Stage 2018-505434 Issued
NCI E-249-2015-0-JP-09 MODIFIED YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS JP National Stage 2018-505476 Issued
NIDCR E-026-2018-1-US-01 USE OF COPEPTIN TO MODULATE THE IMMUNE RESPONSE AND HEMATOPOIESIS, AND STIMULATE BONE US 62/625,242 Abandoned
NCI E-215-2017-0-US-01 STEREOSELECTIVE SYNTHESIS AND PROCESS FOR THE MANUFACTURING OF 2'-DEOXYNUCLEOSIDES US 62/624,967 Abandoned
NEI E-094-2016-0-AU-04 DEVICES FOR TISSUE CRYOPRESERVATION AND RECOVERY AU National Stage 2018214954 Issued
NCI E-142-2014-0-US-03 ANTIGEN-BINDING PROTEINS TARGETING CD56 AND USES THEREOF US CON 15/884,608 10730941 Issued PDF
NCI E-244-2015-0-US-10 BRACHYURY DELETION MUTANTS, NON-YEAST VECTORS ENCODING BRACHYURY DELETION MUTANTS, AND THEIR USE US National Stage 15/749,214 10550164 Issued PDF
NEI E-094-2016-0-PCT-02 DEVICES FOR TISSUE CRYOPRESERVATION AND RECOVERY PCT PCT PCT/US2018/016101 Expired
NEI E-094-2016-0-EP-06 DEVICES FOR TISSUE CRYOPRESERVATION AND RECOVERY EP National Stage 18704773.3 Pending
NEI E-094-2016-0-JP-07 DEVICES FOR TISSUE CRYOPRESERVATION AND RECOVERY JP National Stage 2019-538157 Abandoned
NEI E-094-2016-0-CA-05 DEVICES FOR TISSUE CRYOPRESERVATION AND RECOVERY CA National Stage 3048523 Pending
NCI E-231-2015-0-SG-08 Near Infrared Photoimmunotherapy (NIR-PIT) of Suppressor Cells to Treat Cancer SG National Stage 11201800787W Issued
NICHD E-072-2017-0-PCT-02 RECOMBINANT VIRUS VECTORS FOR THE TREATMENT OF GLYCOGEN STORAGE DISEASE PCT PCT PCT/US2018/015957 Expired
NICHD E-072-2017-0-EP-05 RECOMBINANT VIRUS VECTORS FOR THE TREATMENT OF GLYCOGEN STORAGE DISEASE EP National Stage 18707167.5 Abandoned
NICHD E-072-2017-0-JP-06 RECOMBINANT VIRUS VECTORS FOR THE TREATMENT OF GLYCOGEN STORAGE DISEASE JP National Stage 2019-540667 Abandoned
NICHD E-072-2017-0-AU-03 RECOMBINANT VIRUS VECTORS FOR THE TREATMENT OF GLYCOGEN STORAGE DISEASE AU National Stage 2018212002 Abandoned
NICHD E-072-2017-0-CA-04 RECOMBINANT VIRUS VECTORS FOR THE TREATMENT OF GLYCOGEN STORAGE DISEASE CA National Stage 3050917 Abandoned
NCI E-249-2015-0-IL-08 MODIFIED YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONS IL National Stage 257208 Issued
NCI E-069-2018-0-US-01 Nucleic Acid Nanoparticles (NANP) and Methods of Using Same for Controlled Immunomodulation US 62/623,496 Abandoned
NCI E-221-2015-0-US-03 ANTIBODY-DRUG CONJUGATES FOR TARGETING CD56-POSITIVE TUMORS US National Stage 15/747,620 10548987 Issued PDF
NCATS E-046-2018-2-PCT-01 AUTOPHAGY INDUCERS FOR TREATMENT OF CNS CONDITIONS PCT PCT COMB PCT/US2018/015293 Expired
NEI E-044-2018-0-US-01 BMSC DERIVED EXOSOMES AND MIRNA TO TREAT GLAUCOMA US 62/622,032 Abandoned
NCI E-244-2015-0-IL-07 Brachyury Deletion Mutants, Non-Yeast Vectors Encoding Brachyury Deletion Mutants, and Their Use IL National Stage 257127 Issued
NCI E-171-2018-7-IL-04 MODIFIED CELLS AND METHODS OF THERAPY IL National Stage 257105 Issued
NICHD E-030-2018-0-US-01 METHODS AND COMPOSITIONS FOR TREATING LYSOSOMAL STORAGE DISEASES US 62/620,811 Abandoned
NINDS E-088-2018-0-TW-04 Anti-HERV-K Envelope Antibody And Uses Thereof TW ORD 107102219 Issued
NEI E-284-2012-2-US-07 METHODS AND COMPOSITIONS FOR TREATING GENETICALLY LINKED DISEASES OF THE EYE US CON 15/876,821 1035-03-06 Issued PDF
NCI E-116-2017-2-US-01 Compositions and Methods For Treating Cancer With Anti-CD33 Immunotherapy US 62/620,139 Abandoned
NIAID E-033-2018-0-US-01 BROADLY PROTECTIVE INACTIVATED INFLUENZA VIRUS VACCINE US 62/620,051 Abandoned
NINDS E-088-2018-1-CN-04 Amti-HERV-K Envelope Antibody and Uses Thereof CN National Stage 201880014059.2 Issued
NHLBI E-134-2017-3-CN-06 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 CN National Stage 201880019604.7 Issued
NHLBI E-134-2017-3-JP-11 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 JP National Stage 2019-539809 Issued
NHLBI E-134-2017-3-EA-07 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 EA National Stage 201991491 Issued
NINDS E-088-2018-1-JP-08 Amti-HERV-K Envelope Antibody and Uses Thereof JP National Stage 2019-539822 Issued
NHLBI E-134-2017-3-AU-03 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 AU National Stage 2018210404 Issued
NHLBI E-134-2017-3-PCT-01 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 PCT PCT COMB PCT/US2018/014532 Expired
NINDS E-088-2018-1-PCT-01 Amti-HERV-K Envelope Antibody and Uses Thereof PCT PCT COMB PCT/US2018/014489 Expired
NINDS E-088-2018-0-AR-02 Anti-HERV-K Envelope Antibody And Uses Thereof AR ORD 20180100129 Pending
NHLBI E-134-2017-3-EP-08 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 EP National Stage 18742118.5 Pending
NINDS E-088-2018-1-EP-06 Amti-HERV-K Envelope Antibody and Uses Thereof EP National Stage 18713060.4 Pending
NHGRI E-212-2020-0-US-01 System And Method For Estimating A Quantity Of Interest Based On An Image Of A Histological Section US 62/619,447 Abandoned
NCI E-236-2017-0-US-01 ANTI-CANCER ACTIVITY OF SCGB3A2 AND LPS US 62/619,511 Abandoned
NINDS E-088-2018-1-EA-05 Amti-HERV-K Envelope Antibody and Uses Thereof EA National Stage 201991736 Pending
NHLBI E-134-2017-3-BR-04 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 BR National Stage BR1120190147071 Pending
NINDS E-088-2018-1-AU-02 Anti-HERV-K Envelope Antibody and Uses Thereof AU National Stage 2018210388 Pending
NINDS E-088-2018-1-CA-03 Amti-HERV-K Envelope Antibody and Uses Thereof CA National Stage 3050286 Pending
NHLBI E-134-2017-3-CA-05 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 CA National Stage 3050106 Pending
NHLBI E-134-2017-3-SG-15 APOC-II MIMETIC PEPTIDES SG National Stage 11201906422V Abandoned
NHLBI E-134-2017-3-ZA-16 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 ZA National Stage 2019/04733 Pending
NHLBI E-134-2017-3-MX-13 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 MX National Stage MX/a/2019/008529 Pending